Elaine Caughey serves as Executive at Kymera Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Elaine Caughey has executed 4 insider transactions totaling $22.1K, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 2, 2023 involved selling 550 shares valued at $17.0K.
Elaine Caughey currently holds 19,150 shares of Kymera Therapeutics, Inc. (KYMR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Elaine Caughey has been a net seller of KYMR stock. They have purchased $0 and sold $22.1K worth of shares.
Elaine Caughey's most recent insider trade was on Mar 2, 2023, when they sold 550 shares at $30.88 per share.
Get notified when new Form 4 filings are submitted
| $31.40 |
| Discretionary |
| Mar 1, 2023 | KYMR | $0 | Award | 10,557 | $N/A | Discretionary |
| Mar 1, 2022 | KYMR | $0 | Award | 7,000 | $N/A | Discretionary |